查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1386409

胞外体治疗市场报告：2030 年趋势、预测与竞争分析

Exosome Therapeutics Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

胞外体治疗的趋势和预测

预计到 2030 年，全球胞外体治疗市场将达到 18 亿美元，2024 年至 2030 年年复合成长率为 25.7%。这个市场的主要驱动力是人们胞外体疗法潜力的认识不断提高、政府加大胞外体疗法开发和商业化的支持以及全球慢性病盛行率的上升。全球胞外体治疗市场的未来充满希望，研究和学术机构以及医院和诊断中心市场存在机会。

胞外体治疗市场洞察

Lucintel 预测，在预测期内，天然外吐小体将继续成为最大的细分市场，因为它们比混合外吐小体更丰富、更容易製造、更俱生物相容性并且保质期更长。

由于胞外体治疗研究的高需求，预计研究和学术机构将继续占据该市场的很大一部分。

由于其强大的研发基础设施和有利的法规环境，北美仍然是我们最大的市场。

本报告回答了 11 个关键问题：

  • Q.1. 细分市场中最有前途和高成长的机会是什么？
  • Q.2.哪个细分市场将以更快的速度成长？为什么？
  • Q.3.您认为哪些地区未来会出现更快的成长？为什么？
  • Q.4. 影响市场动态的主要因素有哪些？市场的主要挑战和商业风险是什么？
  • Q.5. 这个市场的商业风险和竞争威胁是什么？
  • Q.6.这个市场有哪些新趋势？为什么？
  • Q.7.市场客户需求有何改变？
  • Q.8. 该市场有哪些新发展以及哪些公司处于领先地位？
  • Q.9.这个市场的主要企业有哪些？主要企业采取哪些策略配合措施来发展业务？
  • Q.10. 该市场上的竞争产品有哪些？由于材料或产品替代而导致市场占有率下降的威胁有多大？
  • Q.11.过去年度发生了哪些併购事件，对产业产生了哪些影响？

目录

第1章执行摘要

第2章全球胞外体治疗市场：市场动态

  • 简介、背景、分类
  • 供应链
  • 产业驱动因素与挑战

第3章2018-2030年市场趋势及预测分析

  • 宏观经济趋势（2018-2023）与预测（2024-2030）
  • 全球胞外体治疗市场趋势（2018-2023）与预测（2024-2030）
  • 按类型分類的全球胞外体治疗市场
    • 天然胞外体
    • 混合胞外体
  • 全球胞外体治疗市场（按应用）
    • 代谢紊乱
    • 肿瘤学
    • 心臟病
    • 神经病学
    • 发炎疾病
    • 器官移植
    • 妇科疾病
    • 血液疾病
    • 其他的
  • 全球胞外体治疗市场（依最终用途）
    • 研究和学术机构
    • 医院和诊断中心

第4章2018-2030年分地区市场趋势及预测分析

  • 全球胞外体治疗市场（按地区）
  • 北美胞外体治疗市场
  • 欧洲胞外体治疗市场
  • 亚太胞外体治疗市场
  • 其他区域胞外体治疗市场

第5章竞争分析

  • 产品系列分析
  • 营运整合
  • 波特五力分析

第6章成长机会与策略分析

  • 成长机会分析
    • 按类型分類的全球胞外体治疗市场成长机会
    • 全球胞外体治疗市场成长机会（按应用）
    • 全球胞外体治疗市场成长机会（依最终用途）
    • 按地区分類的全球胞外体治疗市场成长机会
  • 全球胞外体治疗市场新趋势
  • 战略分析
    • 新产品开发
    • 扩大全球胞外体治疗市场的产能
    • 全球胞外体治疗市场的合併、收购与合资企业
    • 认证和许可

第7章主要企业概况

  • Church & Dwight
  • GSK
  • Pfizer
  • Sun Pharmaceutical
  • Takeda Pharmaceutical
  • F. Hoffmann-La Roche
  • CELGENE Corporation
简介目录

Exosome Therapeutics Trends and Forecast

The future of the global exosome therapeutics market looks promising with opportunities in the research & academic institute and hospital & diagnostic center markets. The global exosome therapeutics market is expected to reach an estimated $1.8 billion by 2030 with a CAGR of 25.7% from 2024 to 2030. The major drivers for this market are increasing awareness towards the potential of exosome therapeutics, growing government supports for development and commercialization of exosome therapeutics, and rising prevalence of chronic diseases across the globe.

A more than 150-page report is developed to help in your business decisions.

Exosome Therapeutics by Segment

The study includes a forecast for the global exosome therapeutics by type, application, end use, and region.

Exosome Therapeutics Market by Type [Shipment Analysis by Value from 2018 to 2030]:

  • Natural Exosome
  • Hybrid Exosome

Exosome Therapeutics Market by Application [Shipment Analysis by Value from 2018 to 2030]:

  • Metabolic Disorders
  • Oncology
  • Cardiac Disorders
  • Neurology
  • Inflammatory Disorders
  • Organ Transplantation
  • Gynecology Disorders
  • Blood Disorders
  • Others

Exosome Therapeutics Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Research & Academic Institutes
  • Hospitals & Diagnostic Centers

Exosome Therapeutics Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Exosome Therapeutics Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies exosome therapeutics companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the exosome therapeutics companies profiled in this report include-

  • Church & Dwight
  • GSK
  • Pfizer
  • Sun Pharmaceutical
  • Takeda Pharmaceutical
  • F. Hoffmann-La Roche
  • Celgene Corporation

Exosome Therapeutics Market Insights

Lucintel forecasts that natural exosome will remain the largest segment over the forecast period due to as more abundant, easier to produce, more biocompatible, and have a longer shelf life than hybrid exosomes.

Within this market, research and academic institutes is expected to remain the larger segment due to high demand for exosome therapeutics research.

North America will remain the largest region due to well-funded research and development infrastructure and the favorable regulatory environment in the region.

Features of the Global Exosome Therapeutics Market

Market Size Estimates: Exosome therapeutics market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Exosome therapeutics market size by type, application, end use, and region in terms of value ($B).

Regional Analysis: Exosome therapeutics market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, applications, end uses, and regions for the exosome therapeutics market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the exosome therapeutics market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the exosome therapeutics market size?

Answer: The global exosome therapeutics market is expected to reach an estimated $1.8 billion by 2030.

Q.2 What is the growth forecast for exosome therapeutics market?

Answer: The global exosome therapeutics market is expected to grow with a CAGR of 25.7% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the exosome therapeutics market?

Answer: The major drivers for this market are increasing awareness towards the potential of exosome therapeutics, growing government supports for development and commercialization of exosome therapeutics, and rising prevalence of chronic diseases across the globe.

Q4. What are the major segments for exosome therapeutics market?

Answer: The future of the exosome therapeutics market looks promising with opportunities in the research & academic institute and hospital & diagnostic center markets.

Q5. Who are the key exosome therapeutics market companies?

Answer: Some of the key exosome therapeutics companies are as follows:

  • Church & Dwight
  • GSK
  • Pfizer
  • Sun Pharmaceutical
  • Takeda Pharmaceutical
  • F. Hoffmann-La Roche
  • Celgene Corporation

Q6. Which exosome therapeutics market segment will be the largest in future?

Answer: Lucintel forecasts that natural exosome will remain the larger segment over the forecast period as it is abundant in nature, more biocompatible, and possess a longer shelf life than hybrid exosomes.

Q7. In exosome therapeutics market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region due to well-funded research and development infrastructure and the favorable regulatory environment in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the exosome therapeutics market by type (natural exosome and hybrid exosome), application (metabolic disorders, oncology, cardiac disorders, neurology, inflammatory disorders, organ transplantation, gynecology disorders, blood disorders, and others), end use (research & academic institutes and hospitals & diagnostic centers), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Exosome Therapeutics Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Exosome Therapeutics Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Exosome Therapeutics Market by Type
    • 3.3.1: Natural Exosome
    • 3.3.2: Hybrid Exosome
  • 3.4: Global Exosome Therapeutics Market by Application
    • 3.4.1: Metabolic Disorders
    • 3.4.2: Oncology
    • 3.4.3: Cardiac Disorders
    • 3.4.4: Neurology
    • 3.4.5: Inflammatory Disorders
    • 3.4.6: Organ Transplantation
    • 3.4.7: Gynecology Disorders
    • 3.4.8: Blood Disorders
    • 3.4.9: Others
  • 3.5: Global Exosome Therapeutics Market by End Use
    • 3.5.1: Research & Academic Institutes
    • 3.5.2: Hospitals & Diagnostic Centers

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Exosome Therapeutics Market by Region
  • 4.2: North American Exosome Therapeutics Market
    • 4.2.2: North American Exosome Therapeutics Market by End Use: Research & Academic Institutes and Hospitals & Diagnostic Centers
  • 4.3: European Exosome Therapeutics Market
    • 4.3.1: European Exosome Therapeutics Market by Type: Natural Exosome and Hybrid Exosome
    • 4.3.2: European Exosome Therapeutics Market by End Use: Research & Academic Institutes and Hospitals & Diagnostic Centers
  • 4.4: APAC Exosome Therapeutics Market
    • 4.4.1: APAC Exosome Therapeutics Market by Type: Natural Exosome and Hybrid Exosome
    • 4.4.2: APAC Exosome Therapeutics Market by End Use: Research & Academic Institutes and Hospitals & Diagnostic Centers
  • 4.5: ROW Exosome Therapeutics Market
    • 4.5.1: ROW Exosome Therapeutics Market by Type: Natural Exosome and Hybrid Exosome
    • 4.5.2: ROW Exosome Therapeutics Market by End Use: Research & Academic Institutes and Hospitals & Diagnostic Centers

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Exosome Therapeutics Market by Type
    • 6.1.2: Growth Opportunities for the Global Exosome Therapeutics Market by Application
    • 6.1.3: Growth Opportunities for the Global Exosome Therapeutics Market by End Use
    • 6.1.4: Growth Opportunities for the Global Exosome Therapeutics Market by Region
  • 6.2: Emerging Trends in the Global Exosome Therapeutics Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Exosome Therapeutics Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Exosome Therapeutics Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Church & Dwight
  • 7.2: GSK
  • 7.3: Pfizer
  • 7.4: Sun Pharmaceutical
  • 7.5: Takeda Pharmaceutical
  • 7.6: F. Hoffmann-La Roche
  • 7.7: CELGENE Corporation